What's New

August

Proposed Rule: Removal of 6β-naltrexol From Control (August 21, 2019)

Final Rule: Listing of Noroxymorphone in the Code of Federal Regulations and Assignment of a Controlled Substances Code Number (August 16, 2019)

Peter John Ulbrich, M.D.; Decision and Order (August 16, 2019)

Brent E. Silvers, M.D.; Decision and Order (August 16, 2019)

Alcami Wisconsin Corporation (August 8, 2019)

Parth S. Bharill; Decision and Order (August 8, 2019)

Anthony Schapera, M.D.; Decision and Order (August 8, 2019)

July

Importer of Controlled Substances Registration (July 30, 2019)

Chemtos, LLC (July 30, 2019)

Research Triangle Institute (July 30, 2019)

AMPAC Fine Chemicals LLC (July 30, 2019)

Alcami Carolinas Corporation (July 30, 2019)

Research Triangle Institute (July 30, 2019)

Cambrex Charles City (July 30, 2019)

Catalent Pharma Solutions, LLC (July 30, 2019)

Xcelience (July 30, 2019)

Nostrum Laboratories, Inc. (July 30, 2019)

Southern Ohio Correctional Facility (July 30, 2019)

Chattem Chemicals (July 30, 2019)

IsoSciences, LLC (July 24, 2019)

Cardinal Health (July 24, 2019)

Restek Corporation (July 24, 2019)

AMRI Rensselaer, Inc. (July 24, 2019)

Temporary Scheduling Order: Temporary Placement of N-Ethylhexedrone, α-PHP, 4–MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I (July 18, 2019)

Importer of Controlled Substances Registration (July 2, 2019)

Absolute Standards, Inc. (July 2, 2019)

Pisgah Laboratories, Inc. (July 2, 2019)

Sigma Aldrich Co., LLC (July 2, 2019)

Bellwyck Clinical Services (July 2, 2019)

Lipomed (July 2, 2019)

June

VHG Labs DBA LGC Standards (June 24, 2019)

Final Rule: Placement of Thiafentanil in Schedule II (June 18, 2019)

Importer of Controlled Substances Registration (June 17, 2019)

Interim Final Rule: Placement of Brexanolone in Schedule IV (June 17, 2019)

Interim Final Rule: Placement of Solriamfetol in Schedule IV (June 17, 2019)

Bulk Manufacturer of Controlled Substances Registration (June 13, 2019)

Sigma Aldrich Research (June 13, 2019)

Eli-Elsohly Laboratories (June 13, 2019)

Elizabeth C. Korcz, M.D.; Decision and Order (June 13, 2019)

Bulk Manufacturer of Controlled Substances Registration (June 6, 2019)

American Radiolabeled Chem (June 6, 2019)

SpecGx LLC (June 6, 2019)

Shertech Laboratories, LLC (June 6, 2019)

May

Importer of Controlled Substances Registration (May 22, 2019)

United States Pharmacopeial Convention (May 22, 2019)

30-Day Notice: Report of Mail Order Transactions (May 21, 2019)

Importer of Controlled Substances Registration (May 15, 2019)

Bulk Manufacturer of Controlled Substances Registration (May 15, 2019)

AMPAC Fine Chemicals Virginia, LLC (May 15, 2019)

Raquel Skidmore, M.D.; Decision and Order (May 15, 2019)

Fred J. Powell, M.D.; Decision and Order (May 15, 2019)

Rhodes Technologies (May 15, 2019)

Wildlife Laboratories, Inc. (May 15, 2019)

AndersonBrecon Inc. DBA PCI of Illinois (May 15, 2019)

S & B Pharma, Inc. (May 15, 2019)

AndersonBrecon, Inc. (May 15, 2019)

Final Rule: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I; Correction (May 8, 2019)

Final Rule: Placement of beta-Hydroxythiofentanyl in Schedule I (May 8, 2019)

Notice of Intent: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I (May 1, 2019)

April

Final Rule: Interlocutory Appeals in Administrative Hearings (April 30, 2019)

Palafox Pharmacy; Decision and Order (April 30, 2019)

Mylan Pharmaceuticals Inc. (April 30, 2019)

Chemical Names of Previously Controlled Fentanyl-Related Substances (April 19, 2019)

Temporary Order: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I (April 16, 2019)

Temporary Rule: Extension of Temporary Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I of the Controlled Substances Act (April 8, 2019)

Proposed Rule: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I (April 8, 2019)

Importer of Controlled Substances Registration (April 8, 2019)

Bulk Manufacturer of Controlled Substances Registration (April 8, 2019)

Synthcon, LLC (April 8, 2019)

Martin A. Barrios, M.D.; Decision and Order (April 8, 2019)

Craig M. Weingrow, M.D.; Decision and Order (April 8, 2019)

Richard Carter, M.D.; Decision and Order (April 8, 2019)

Sanyal Biotechnology, LLC (April 8, 2019)

SpecGx LLC (April 8, 2019)

Organic Standards Solutions International, LLC (April 8, 2019)

Unither Manufacturing LLC (April 8, 2019)

March

Siemens Healthcare Diagnostics Inc. (March 21, 2019)

Fisher Clinical Services, Inc. (March 21, 2019)

Joel A. Smithers, D.O.; Decision and Order (March 18, 2019)

William A. Sanpablo, M.D.; Decision and Order (March 18, 2019)

Sharp (Bethlehem), LLC (March 18, 2019)

Importer of Controlled Substances Registration (March 6, 2019)

Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)

Patheon Pharmaceuticals, Inc. (March 6, 2019)

S&B Pharma Inc. (March 6, 2019)

Siegfried USA, LLC (March 1, 2019)

Meridian Medical Technologies (March 1, 2019)